Craif Inc. secures US$22 million in series C funding to advance early cancer detection platform
Craif Inc., a molecular diagnostics company pioneering early cancer detection through microRNA (miRNA) analysis, has completed the second close of its Series C funding round, bringing the total to US$22…
Read more